Introduction
Polyspecific organic cation transporters (OCTs) belong to the solute carrier SLC22 superfamily of transporters, and they translocate a wide variety of endogenous and exogenous substances of cationic nature. There are three isoforms of OCTs, namely OCT1, OCT2 and OCT3, with similar membrane topology consisting of 12 transmembrane domains. [1] Of these, OCT1 is one of the most abundantly expressed transporters in the liver and plays a major role in the hepatic uptake and renal transport of the biguanide agent, metformin. [2] Metformin is an oral antidiabetic drug, widely used for treating type 2 diabetes mellitus as first-line monotherapy. The main action of metformin is the suppression of hepatic gluconeogenesis. [3] In vivo studies have shown that the concentration of metformin in liver was greatly decreased in OCT1 gene knockout mice than in mice with normal OCT1 transporter activity. [4] The gene encoding human OCT1, also termed SLC22A1, is mapped onto chromosome 6q25.3 and consists of 11 exons spanning 37 kb. Human OCT1 gene is highly polymorphic, and numerous polymorphisms have been described in various populations leading to differences in transporter function. [2, 4] For all subjects, 5 ml of venous blood was collected using EDTA as an anticoagulant. Genomic DNA was extracted from peripheral blood leucocytes using the standard phenol-chloroform method, and the samples were stored at 4°C.
Genotyping rs2282143 and rs622342
Genotyping for rs2282143 and rs622342 was carried out using a Real Time Thermocycler (ABI Prism 7300, Foster city, CA, USA) using the TaqMan SNP genotyping assay method. C__11764545_20 was used as the SNP genotyping assay ID (Applied Biosystems, Foster City, CA, USA) for rs2282143 and TaqMan custom genotyping assay was used for rs622342 polymorphism. 
rs628031
Genotyping of rs628031 was determined by PCR followed by restriction fragment length polymorphism.
PCR was performed using the following primers:
respectively. The PCR conditions used for amplification were as follows. An initial denaturation at 94°C for 5 min followed by 32 cycles of denaturation at 94°C for 30 s, annealing at 63°C for 45 s and extension at 72°C for 1 min, with a final extension at 72°C for 5 min.
The amplified products (397 bp) were analyzed on 1% agarose gel followed by restriction digestion using Figure 1 ]. The accuracy and reliability of all the genotyping methods were further confirmed by direct DNA sequencing (Macrogen, South Korea).
Statistical analysis: Data analysis was performed using Instat Graph pad 3. The direct gene counting method was used to determine the frequency of genotypes and alleles. The genotype data was analyzed using Chi-square and Fischer's exact test. The observed frequencies were compared with the expected frequencies and tested for the Hardy-Weinberg equilibrium. Differences in allele frequencies between Tamilian and other ethnic populations were measured using the Chi-square test and Fisher's exact test. Linkage disequilibrium (LD) was calculated using Haploview software version 4.1. A P-value <0.05 was considered statistically significant. Table 1 Table 2 ].
Results

Discussion
In recent years, OCT1 gene polymorphisms have gained considerable attention due to their role in the # Patients; n, number; nd, not determined; * P < 0.05; ** P < 0.01; *** P < 0.0001 compared with Tamilians differential response of metformin. In this study, we addressed the frequency of three previously described polymorphisms of the OCT1 gene in 112 healthy volunteers of South Indian Tamilian population, and the data was compared with other published studies. OCT1 gene polymorphisms were found to be common, but the distribution of the variant allele frequencies showed significant interethnic variations [ Table 2 ]. To the best of our knowledge, this is the first study to document the frequencies of OCT1 gene polymorphisms in any of the Indian populations. The polymorphism associated with decreased transporter activity rs2282143 was detected at 8.9% in this study, which was comparable to the data obtained from Chinese (11%), Vietnamese (5.5%), [8] Asians residing in USA (11.7%) and African-Americans (8.2%). [7] On the other hand, it was lower than those observed in North East Asians from Japan (16.8%) [9] and Korea (16.7%). [8] Likewise, it was significantly higher than those reported in European Caucasians (0-2%). [7, 8] In the present study, the frequency of rs628031 genotypes was significantly (P < 0.001) lower in the Tamilian population than expected based on the HardyWeinberg calculations. The rs628031, Met408Val polymorphism might have accumulated over generations, which perhaps led to substantial changes in Tamilian population. Nevertheless, the frequency of 80.3% obtained for the rs628031 G allele was similar to other Asian populations previously described in Koreans (74%), [8] Japanese (81%), [9] Asians living in the USA (76.2%) and African-Americans (73.5%). [7] However, it was significantly higher than European Caucasians from the USA (59.8%), [7] Germany (57.4%) [10] and the Netherlands (60.3%). [5] The occurrence of relatively low frequency of rs2282143 and rs628031 OCT1 gene polymorphisms in Caucasians suggests that the impaired OCT1 transport activity may vary between Asians, Africans and Caucasians.
The SNP rs622342 was first identified by Becker et al. in Dutch diabetic patients with a frequency of about 37%, which was higher than the Tamilians (24.5%) observed in the present study. They assessed the association of OCT1 gene polymorphism with the glucose-lowering effect of metformin, and found that the metformin therapy was less-effective in individuals with heterozygous (AC) and homozygous (CC) mutant carriers of rs622342 OCT1 gene polymorphism. [5] Later on, in another study interaction between OCT1 (rs622342) and MATE1 (rs2289669), genes were observed in relation to metformin response. [11] Furthermore, a study conducted in healthy Caucasian male subjects has shown that the polymorphisms of OCT1 were associated with increased renal clearance of metformin. [10] Recently, studies have correlated the expression level of OCT1 gene with the intracellular concentration of imatinib, an anticancer drug, and have found that chronic myeloid leukemia patients who had higher baseline expression levels of OCT1 showed greater progression-free survival rates. [12, 13] More recently, a population-based cohort study has suggested that patients with AC and CC genotypes of rs622342 polymorphism will have reduced response to anti-Parkinsonian drugs. [14] This explains that the polymorphisms of OCT1 will also show variable response to imatinib and anti-Parkinsonian drugs.
Indians are more prone to diabetes, and its prevalence is becoming an enormous health burden in the country, which has gone beyond epidemic to pandemic proportions. According to the International Diabetes Federation, it has been estimated that the number of diabetic patients in India will increase from 50.8 million to 79.4 million by 2030 (Prevalence of Diabetes available at www.idf.org, assessed on December 23, 2010). In the context of India being the "diabetic capital" of the world and metformin is the most commonly used antidiabetic drug in India, the pattern and frequency of OCT1 gene polymorphisms observed in this study becomes important indicating the prevalence of variant alleles in this region. However, it does not reveal a direct evidence for genotype-phenotype correlation. Further, information on the prevalence of OCT1 gene polymorphisms in populations of different ethnic origin may be essential in explaining the interpatient and interethnic differences in the disposition and distribution of organic cationic drugs such as metformin, imatinib and levodopa. In conclusion, our observation provides a framework for future correlation studies on the relevance of OCT1 variants in response to drugs that are substrates of OCT1.
